Description
IGF::CL::IGF NEW MOLECULAR INFECTIOUS DISEASES BPA CONTRACT
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-29+$870,000= $870,000
- Mod P000012017-01-05+$41,000= $911,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-29 | +$870,000 | $870,000 | IGF::CL::IGF NEW MOLECULAR INFECTIOUS DISEASES BPA CONTRACT |
| Mod P00001· FUNDING ONLY ACTION | 2017-01-05 | +$41,000 | $911,000 | IGF::CL::IGF NEW MOLECULAR INFECTIOUS DISEASES BPA CONTRACT |
Related awards · 8
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under Q301 from 688-WASHINGTON DC (00688)(36C688) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24516F0568 | CEPHEID | 688-WASHINGTON DC (00688)(36C688) | $11,340 | FY2016 |
| VA24515A0074 | ROCHE DIAGNOSTICS CORPORATION | 688-WASHINGTON DC (00688)(36C688) | $0 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24515F1139_3600_VA24513A0025_3600 · retrieved 2026-09-26.